Inactive Instrument

News Lotus Pharmaceuticals, Inc. Other OTC

Equities

LTUS

US5457152032

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

Lotus Achieves Historic Q3 2023 Results with YTD EPS Soaring to a Record NTD 14.19 Marking a 29% Year-on-Year Growth	Nov. 10	AQ
Lotus Continued Stelar Growth in 2Q 2023 EPS Recorded NTD 4.85 with 285% Growth Year on Year	23-09-12	AQ
Lotus Continued Stelar Growth in 2Q 2023 EPS Recorded NTD 4.85 with 285% Growth Year on Year	23-08-14	AQ
AMARIN AND LOTUS PHARMACEUTICALS ANNOUNCE EXCLUSIVE PARTNERSHIP AGREEMENT TO COMMERCIALIZE VAZKEPA IN SOUTHEAST ASIA AND SOUTH KOREA	23-08-01	AQ
Amarin, Lotus Pharmaceuticals Agree to Exclusive Vazkepa Distribution Deal in 10 Asian Countries	23-07-31	MT
Lotus Announces MFDS Approval for GRALISE SR, Once-Daily Tablets for Post-Herpetic Neuralgia	23-03-27	AQ
Lotus revenues grow by 16% and profit doubles year over year	23-03-13	AQ
Lotus acquires Alimta in Taiwan from Lilly	22-12-14	AQ
Lotus Pharmaceuticals - Aztiq and Innobic officially become Lotus's majority shareholders	22-07-12	AQ
Lotus Reports Solid Performance in First Quarter of 2022	22-05-16	AQ
Lotus Pharmaceuticals : Unaudited Financial Statement	22-03-30	PU
Lotus Pharmaceuticals acquires Cialis (Tadalafil) in Taiwan from Lilly	22-03-23	AQ
Lotus achieves another record high EPS for FY2021	22-03-17	AQ
A powerful investment alliance of Aztiq and Innobic acquires Alvogen's shares in Lotus and Adalvo in a US$475m deal	21-11-29	AQ
Thai oil firm PTT expands pharma business with $475 million Alvogen deal	21-11-26	RE
Lotus Pharmaceuticals : Informational Disclosure	21-11-22	PU
Lotus Pharmaceuticals : Unaudited Financial Statements	21-11-22	PU
Lotus Pharmaceuticals : Temasek-backed Vertex expects at least $400 million in new S.E.Asia/India fund	21-09-28	RE
Lotus Pharmaceuticals : PTT invests in Lotus	21-04-19	AQ
LOTUS PHARMACEUTICALS, INC. : Other Events (form 8-K)	20-02-26	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Lotus Pharmaceuticals, Inc. Other OTC

Equities

LTUS

US5457152032

Summary

Filters